These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10421757)

  • 21. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic retinoids: structure-activity relationships.
    Barnard JH; Collings JC; Whiting A; Przyborski SA; Marder TB
    Chemistry; 2009 Nov; 15(43):11430-42. PubMed ID: 19821467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of retinoid X receptor transcriptional antagonism.
    Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
    J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
    García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
    Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic retinoids dissociate coactivator binding from corepressor release.
    Zechel C
    J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.
    Sun SY; Kurie JM; Yue P; Dawson MI; Shroot B; Chandraratna RA; Hong WK; Lotan R
    Clin Cancer Res; 1999 Feb; 5(2):431-7. PubMed ID: 10037194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors.
    Wang DL; Marko M; Dahl AR; Engelke KS; Placke ME; Imondi AR; Mulshine JL; De Luca LM
    Clin Cancer Res; 2000 Sep; 6(9):3636-45. PubMed ID: 10999756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner.
    Pendaries V; Verrecchia F; Michel S; Mauviel A
    Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of the RAR interaction domain of cellular retinoic acid binding protein-II.
    Budhu A; Gillilan R; Noy N
    J Mol Biol; 2001 Jan; 305(4):939-49. PubMed ID: 11162104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor.
    Alvarez S; Germain P; Alvarez R; Rodríguez-Barrios F; Gronemeyer H; de Lera AR
    Int J Biochem Cell Biol; 2007; 39(7-8):1406-15. PubMed ID: 17433757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
    Chen JY; Penco S; Ostrowski J; Balaguer P; Pons M; Starrett JE; Reczek P; Chambon P; Gronemeyer H
    EMBO J; 1995 Mar; 14(6):1187-97. PubMed ID: 7720709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
    Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.
    Amano Y; Noguchi M; Nakagomi M; Muratake H; Fukasawa H; Shudo K
    Bioorg Med Chem; 2013 Jul; 21(14):4342-50. PubMed ID: 23685180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists.
    Germain P; Gaudon C; Pogenberg V; Sanglier S; Van Dorsselaer A; Royer CA; Lazar MA; Bourguet W; Gronemeyer H
    Chem Biol; 2009 May; 16(5):479-89. PubMed ID: 19477412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked improvement induced in photoaged skin of hairless mouse by ER36009, a novel RARgamma-specific retinoid, but not by ER35794, an RXR-selective agonist.
    Sakuta T; Kanayama T
    Int J Dermatol; 2006 Nov; 45(11):1288-95. PubMed ID: 17076708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists.
    Klein ES; Pino ME; Johnson AT; Davies PJ; Nagpal S; Thacher SM; Krasinski G; Chandraratna RA
    J Biol Chem; 1996 Sep; 271(37):22692-6. PubMed ID: 8798442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.